Symrise Detailed Consensus
Consensus as of: 2024-04-24
*) Normalized for one time effects in segment S&C

KPI[EUR m]Q1 2023FY 2023Q1 2024 EFY 2024 EFY 2025 EFY 2026 EFY 2027 EFY 2028 E
SalesNumber of Estimates14212018105
SalesHighest1,403.75,126.05,515.76,014.06,557.27,154.3
SalesConsensus1,230.24,730.21,272.34,932.95,232.55,576.25,957.86,464.6
SalesMedian1,266.74,915.05,212.55,571.55,937.06,300.0
SalesLowest1,191.04,797.25,074.65,374.85,687.46,214.0
Price/Volume (%)Number of Estimates13161515105
Price/Volume (%)Highest14.59.77.76.76.76.6
Price/Volume (%)Consensus10.67.99.17.16.16.26.26.2
Price/Volume (%)Median8.66.96.36.26.26.3
Price/Volume (%)Lowest5.75.83.35.85.86.0
M&A (%)Number of Estimates1214131395
M&A (%)Highest0.00.02.72.72.72.7
M&A (%)Consensus2.30.8-0.2-0.30.10.20.40.5
M&A (%)Median0.00.00.00.00.00.0
M&A (%)Lowest-0.8-0.8-0.80.00.00.0
FX (%)Number of Estimates1214131395
FX (%)Highest-0.4-0.40.00.00.00.0
FX (%)Consensus-0.1-6.3-5.2-2.80.00.00.00.0
FX (%)Median-5.6-2.60.00.00.00.0
FX (%)Lowest-9.7-5.5-0.20.00.00.0
EBITDA normalized*Number of Estimates-22211894
EBITDA normalized*Highest-1,033.01,158.41,281.11,419.41,570.1
EBITDA normalized*Consensus-903.5-1,000.31,090.61,183.41,293.81,398.3
EBITDA normalized*Median-1,003.51,097.01,184.01,276.01,363.1
EBITDA normalized*Lowest-962.11,037.91,114.81,223.01,296.7
EBITDA-margin (%) normalized*Number of Estimates-21201894
EBITDA-margin (%) normalized*Highest-20.821.622.122.522.0
EBITDA-margin (%) normalized*Consensus-19.1-20.320.821.221.721.5
EBITDA-margin (%) normalized*Median-20.320.921.321.821.7
EBITDA-margin (%) normalized*Lowest-19.319.620.220.620.6
EBITDA reportedNumber of Estimates-22211894
EBITDA reportedHighest-1,033.01,158.41,281.11,419.41,570.1
EBITDA reportedConsensus-851.7-999.71,090.61,183.41,293.81,398.3
EBITDA reportedMedian-1,002.81,097.01,184.01,276.01,363.1
EBITDA reportedLowest-962.11,037.91,114.81,223.01,296.7
EBITDA-margin (%) reportedNumber of Estimates-21201894
EBITDA-margin (%) reportedHighest-20.821.622.122.522.0
EBITDA-margin (%) reportedConsensus-18.0-20.320.821.221.721.5
EBITDA-margin (%) reportedMedian-20.320.921.321.821.7
EBITDA-margin (%) reportedLowest-19.319.620.220.620.6
EBIT reportedNumber of Estimates-21201894
EBIT reportedHighest-763.0852.0955.01,086.21,207.4
EBIT reportedConsensus-559.4-703.3787.7876.7971.81,039.9
EBIT reportedMedian-701.8791.4875.5961.01,020.4
EBIT reportedLowest-677.1714.9800.7859.6911.3
EBIT-margin (%) reportedNumber of Estimates-20191894
EBIT-margin (%) reportedHighest-15.316.216.817.416.9
EBIT-margin (%) reportedConsensus-11.8-14.215.015.716.316.0
EBIT-margin (%) reportedMedian-14.315.015.816.616.2
EBIT-margin (%) reportedLowest-13.213.514.314.514.5
Profit before taxNumber of Estimates-20191794
Profit before taxHighest-664.0756.0852.2992.91,081.4
Profit before taxConsensus-464.9-605.9692.2798.8900.9969.2
Profit before taxMedian-602.5701.0797.0886.0977.0
Profit before taxLowest-567.0581.0730.7789.6841.3
Reported Income for the yearNumber of Estimates-22211894
Reported Income for the yearHighest-487.0555.0626.2722.2795.7
Reported Income for the yearConsensus-340.5-447.9512.4584.8658.7711.9
Reported Income for the yearMedian-446.3513.0587.5650.9718.7
Reported Income for the yearLowest-414.4455.7533.7576.7614.5
Average number of shares (in million)Number of Estimates-2424242422
Average number of shares (in million)Highest-139.77139.77139.77139.77139.77
Average number of shares (in million)Consensus-139.77-139.77139.77139.77139.77139.77
Average number of shares (in million)Median-139.77139.77139.77139.77139.77
Average number of shares (in million)Lowest-139.77139.77139.77139.77139.77
EPS attributable to the shareholders of Symrise - basic reportedNumber of Estimates-22211894
EPS attributable to the shareholders of Symrise - basic reportedHighest-3.483.974.485.175.69
EPS attributable to the shareholders of Symrise - basic reportedConsensus-2.44-3.203.674.184.715.09
EPS attributable to the shareholders of Symrise - basic reportedMedian-3.193.674.204.665.14
EPS attributable to the shareholders of Symrise - basic reportedLowest-2.973.263.824.134.40
DividendNumber of Estimates-20191693
DividendHighest-1.501.792.082.371.98
DividendConsensus-1.10-1.231.351.501.671.69
DividendMedian-1.201.301.401.551.60
DividendLowest-1.091.131.251.301.50
Scent & Care, SalesNumber of Estimates1415131373
Scent & Care, SalesHighest533.41,939.02,037.12,216.92,405.52,612.6
Scent & Care, SalesConsensus454.01,751.8483.81,847.01,948.62,059.12,181.82,356.8
Scent & Care, SalesMedian480.11,840.01,933.02,030.02,132.72,229.3
Scent & Care, SalesLowest450.01,792.81,874.01,977.02,085.82,228.5
Scent & Care Price/Volume (%)Number of Estimates1313111173
Scent & Care Price/Volume (%)Highest17.08.76.05.95.95.6
Scent & Care Price/Volume (%)Consensus4.25.610.46.95.15.45.35.2
Scent & Care Price/Volume (%)Median10.36.55.45.55.55.0
Scent & Care Price/Volume (%)Lowest5.55.51.75.05.05.0
Scent & Care M&A (%)Number of Estimates1212101073
Scent & Care M&A (%)Highest0.00.03.03.03.03.0
Scent & Care M&A (%)Consensus3.50.9-0.1-0.20.20.40.51.0
Scent & Care M&A (%)Median0.00.00.00.00.00.0
Scent & Care M&A (%)Lowest-1.0-1.4-1.20.00.00.0
Scent & Care FX (%)Number of Estimates1212101073
Scent & Care FX (%)Highest0.50.00.00.00.00.0
Scent & Care FX (%)Consensus0.6-3.7-3.3-1.70.00.00.00.0
Scent & Care FX (%)Median-3.6-1.60.00.00.00.0
Scent & Care FX (%)Lowest-6.5-2.9-0.10.00.00.0
Scent & Care, EBITDA normalized*Number of Estimates-15131373
Scent & Care, EBITDA normalized*Highest-346.0381.6428.0463.9510.2
Scent & Care, EBITDA normalized*Consensus-276.7-327.8362.4395.6425.5443.7
Scent & Care, EBITDA normalized*Median-327.3364.0397.2427.4419.8
Scent & Care, EBITDA normalized*Lowest-312.0313.8353.9382.2401.3
Scent & Care, EBITDA-margin (%) normalized*Number of Estimates-15131373
Scent & Care, EBITDA-margin (%) normalized*Highest-18.719.720.321.319.5
Scent & Care, EBITDA-margin (%) normalized*Consensus-15.8-17.818.619.219.518.8
Scent & Care, EBITDA-margin (%) normalized*Median-17.818.819.419.318.8
Scent & Care, EBITDA-margin (%) normalized*Lowest-16.516.317.518.018.0
Scent & Care, EBITDA reportedNumber of Estimates-15131373
Scent & Care, EBITDA reportedHighest-346.0381.6428.0463.9510.2
Scent & Care, EBITDA reportedConsensus-222.4-327.4362.4395.6425.5443.7
Scent & Care, EBITDA reportedMedian-327.3364.0397.2427.4419.8
Scent & Care, EBITDA reportedLowest-312.0313.8353.9382.2401.3
Scent & Care, EBITDA-margin (%) reportedNumber of Estimates-15131373
Scent & Care, EBITDA-margin (%) reportedHighest-18.719.720.321.319.5
Scent & Care, EBITDA-margin (%) reportedConsensus-12.7-17.718.619.219.518.8
Scent & Care, EBITDA-margin (%) reportedMedian-17.818.819.419.318.8
Scent & Care, EBITDA-margin (%) reportedLowest-16.516.317.518.018.0
Taste, Nutrition & Health, SalesNumber of Estimates1415131373
Taste, Nutrition & Health, SalesHighest870.33,232.03,478.63,797.14,151.84,541.7
Taste, Nutrition & Health, SalesConsensus776.12,978.3788.43,087.13,297.33,528.43,783.94,246.2
Taste, Nutrition & Health, SalesMedian788.03,075.03,281.03,506.03,747.24,126.7
Taste, Nutrition & Health, SalesLowest741.03,007.53,181.33,388.13,601.64,070.3
Taste, Nutrition & Health Price/Volume (%)Number of Estimates1313111173
Taste, Nutrition & Health Price/Volume (%)Highest13.09.19.27.57.57.5
Taste, Nutrition & Health Price/Volume (%)Consensus14.69.38.37.16.76.76.87.0
Taste, Nutrition & Health Price/Volume (%)Median8.56.66.76.76.76.9
Taste, Nutrition & Health Price/Volume (%)Lowest5.56.04.36.06.06.5
Taste, Nutrition & Health M&A (%)Number of Estimates1212101073
Taste, Nutrition & Health M&A (%)Highest0.50.52.52.52.52.5
Taste, Nutrition & Health M&A (%)Consensus1.50.7-0.2-0.40.10.30.40.8
Taste, Nutrition & Health M&A (%)Median0.00.00.00.00.00.0
Taste, Nutrition & Health M&A (%)Lowest-1.3-1.3-1.30.00.00.0
Taste, Nutrition & Health FX (%)Number of Estimates1212101073
Taste, Nutrition & Health FX (%)Highest-0.9-0.60.00.00.00.0
Taste, Nutrition & Health FX (%)Consensus-0.6-7.8-6.2-3.20.00.00.00.0
Taste, Nutrition & Health FX (%)Median-6.7-3.20.00.00.00.0
Taste, Nutrition & Health FX (%)Lowest-11.5-5.4-0.30.00.00.0
Taste, Nutrition & Health, EBITDA normalized*Number of Estimates-15131373
Taste, Nutrition & Health, EBITDA normalized*Highest-688.0776.8863.1955.51,059.9
Taste, Nutrition & Health, EBITDA normalized*Consensus-626.8-673.7734.4796.0867.5964.6
Taste, Nutrition & Health, EBITDA normalized*Median-674.0735.0790.0869.1938.4
Taste, Nutrition & Health, EBITDA normalized*Lowest-653.2693.9735.5779.6895.5
Taste, Nutrition & Health, EBITDA-margin (%) normalized*Number of Estimates-15131373
Taste, Nutrition & Health, EBITDA-margin (%) normalized*Highest-22.423.424.024.623.3
Taste, Nutrition & Health, EBITDA-margin (%) normalized*Consensus-21.0-21.822.322.622.922.7
Taste, Nutrition & Health, EBITDA-margin (%) normalized*Median-21.822.322.523.022.7
Taste, Nutrition & Health, EBITDA-margin (%) normalized*Lowest-20.921.521.621.622.0
Taste, Nutrition & Health, EBITDA reportedNumber of Estimates-15131373
Taste, Nutrition & Health, EBITDA reportedHighest-688.0776.8863.1955.51,059.9
Taste, Nutrition & Health, EBITDA reportedConsensus-629.3-673.3734.4796.0867.5964.6
Taste, Nutrition & Health, EBITDA reportedMedian-673.1735.0790.0869.1938.4
Taste, Nutrition & Health, EBITDA reportedLowest-653.2693.9735.5779.6895.5
Taste, Nutrition & Health, EBITDA-margin (%) reportedNumber of Estimates-15131373
Taste, Nutrition & Health, EBITDA-margin (%) reportedHighest-22.423.424.024.623.3
Taste, Nutrition & Health, EBITDA-margin (%) reportedConsensus-21.1-21.822.322.622.922.7
Taste, Nutrition & Health, EBITDA-margin (%) reportedMedian-21.822.322.523.022.7
Taste, Nutrition & Health, EBITDA-margin (%) reportedLowest-20.921.521.621.622.0
Disclaimer

This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.